These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 21335740)

  • 1. Design of Adverse Drug Events-Scorecards.
    Marcilly R; Chazard E; Beuscart-Zéphir MC; Hackl W; Băceanu A; Kushniruk A; Borycki EM
    Stud Health Technol Inform; 2011; 164():377-81. PubMed ID: 21335740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ADE scorecards: a tool for adverse drug event detection in electronic health records.
    Chazard E; Băceanu A; Ferret L; Ficheur G
    Stud Health Technol Inform; 2011; 166():169-79. PubMed ID: 21685622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Routine use of the "ADE scorecards", an application for automated ADE detection in a general hospital.
    Chazard E; Luyckx M; Beuscart JB; Ferret L; Beuscart R
    Stud Health Technol Inform; 2013; 192():308-12. PubMed ID: 23920566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PSIP: an overview of the results and clinical implications.
    Beuscart R
    Stud Health Technol Inform; 2011; 166():3-12. PubMed ID: 21685604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse drug event reporting in intensive care units: a survey of current practices.
    Kane-Gill SL; Devlin JW
    Ann Pharmacother; 2006; 40(7-8):1267-73. PubMed ID: 16849619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scorecards: a new method to prevent adverse drug events? Preliminary results from a clinical field study.
    Marcilly R; Hackl WO; Luyckx M; Ammenwerth E
    Stud Health Technol Inform; 2011; 166():234-45. PubMed ID: 21685629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Building a time-saving and adaptable tool to report adverse drug events.
    Parès Y; Declerck G; Hussain S; Ng R; Jaulent MC
    Stud Health Technol Inform; 2013; 192():903-7. PubMed ID: 23920689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A human factors and survey methodology-based design of a web-based adverse event reporting system for families.
    Daniels JP; King AD; Cochrane DD; Carr R; Shaw NT; Lim J; Ansermino JM
    Int J Med Inform; 2010 May; 79(5):339-48. PubMed ID: 20176502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Data mining to generate adverse drug events detection rules.
    Chazard E; Ficheur G; Bernonville S; Luyckx M; Beuscart R
    IEEE Trans Inf Technol Biomed; 2011 Nov; 15(6):823-30. PubMed ID: 21859604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation and overview of the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance Project (NEISS-CADES).
    Jhung MA; Budnitz DS; Mendelsohn AB; Weidenbach KN; Nelson TD; Pollock DA
    Med Care; 2007 Oct; 45(10 Supl 2):S96-102. PubMed ID: 17909391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of International Classification Of Diseases, 9th Revision, Clinical Modification codes as an adverse drug event surveillance system.
    Hougland P; Xu W; Pickard S; Masheter C; Williams SD
    Med Care; 2006 Jul; 44(7):629-36. PubMed ID: 16799357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expert explorer: a tool for hospital data visualization and adverse drug event rules validation.
    Băceanu A; Atasiei I; Chazard E; Leroy N;
    Stud Health Technol Inform; 2009; 148():85-94. PubMed ID: 19745238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor?
    Trifirò G; Pariente A; Coloma PM; Kors JA; Polimeni G; Miremont-Salamé G; Catania MA; Salvo F; David A; Moore N; Caputi AP; Sturkenboom M; Molokhia M; Hippisley-Cox J; Acedo CD; van der Lei J; Fourrier-Reglat A;
    Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1176-84. PubMed ID: 19757412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication safety program reduces adverse drug events in a community hospital.
    Cohen MM; Kimmel NL; Benage MK; Cox MJ; Sanders N; Spence D; Chen J
    Qual Saf Health Care; 2005 Jun; 14(3):169-74. PubMed ID: 15933311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication errors: an analysis comparing PHICO's closed claims data and PHICO's Event Reporting Trending System (PERTS).
    Benjamin DM; Pendrak RF
    J Clin Pharmacol; 2003 Jul; 43(7):754-9. PubMed ID: 12856390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a computerized adverse drug event monitor.
    Evans RS; Pestotnik SL; Classen DC; Bass SB; Menlove RL; Gardner RM; Burke JP
    Proc Annu Symp Comput Appl Med Care; 1991; ():23-7. PubMed ID: 1807594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of adverse drug events: proposal of a data model.
    Chazard E; Merlin B; Ficheur G; Sarfati JC; ; Beuscart R
    Stud Health Technol Inform; 2009; 148():63-74. PubMed ID: 19745236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early detection of adverse drug events within population-based health networks: application of sequential testing methods.
    Brown JS; Kulldorff M; Chan KA; Davis RL; Graham D; Pettus PT; Andrade SE; Raebel MA; Herrinton L; Roblin D; Boudreau D; Smith D; Gurwitz JH; Gunter MJ; Platt R
    Pharmacoepidemiol Drug Saf; 2007 Dec; 16(12):1275-84. PubMed ID: 17955500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Implementation of a web based software for documentation and control of quality of an acute pain service].
    Pawlik MT; Abel R; Abt G; Kieninger M; Graf BM; Taeger K; Ittner KP
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 Jul; 44(7-8):548-51. PubMed ID: 19629917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for self-reported adverse drug events among Medicare enrollees.
    Oladimeji O; Farris KB; Urmie JG; Doucette WR
    Ann Pharmacother; 2008 Jan; 42(1):53-61. PubMed ID: 18029427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.